- Home
- CLH vs ASND Comparison
CLH vs ASND Comparison
Compare CLH & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CLH | ASND |
|---|---|---|
| Founded | 1980 | 2006 |
| Country | United States | Denmark |
| Employees | N/A | N/A |
| Industry | Environmental Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.2B | 13.6B |
| IPO Year | 1987 | 2015 |
Fundamental Metrics
Financial Performance| Metric | CLH | ASND |
|---|---|---|
| Price | $271.62 | $216.00 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 16 |
| Target Price | $263.83 | ★ $268.19 |
| AVG Volume (30 Days) | 446.7K | ★ 701.7K |
| Earning Date | 02-18-2026 | 02-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 7.20 | N/A |
| Revenue | ★ $5,962,257,000.00 | $845,523,072.00 |
| Revenue This Year | $2.84 | $100.57 |
| Revenue Next Year | $3.81 | $87.16 |
| P/E Ratio | $38.15 | ★ N/A |
| Revenue Growth | 2.85 | ★ 98.03 |
| 52 Week Low | $178.29 | $118.03 |
| 52 Week High | $276.51 | $242.00 |
Technical Indicators
Market Signals| Indicator | CLH | ASND |
|---|---|---|
| Relative Strength Index (RSI) | 65.06 | 48.06 |
| Support Level | $258.80 | $213.02 |
| Resistance Level | $276.51 | $226.40 |
| Average True Range (ATR) | 5.41 | 9.47 |
| MACD | 0.28 | -1.12 |
| Stochastic Oscillator | 67.79 | 21.65 |
Price Performance
Historical ComparisonAbout CLH Clean Harbors Inc.
Clean Harbors Inc is an environmental and industrial services provider. It provides parts cleaning and related environmental services to commercial, industrial, and automotive customers. Its business segments are Environmental Services and Safety-Kleen Sustainability Solutions. The company generates the majority of its revenues from the Environmental Services segment.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.